You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IFN-beta

Showing 1 - 25 of 3,897
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19 Trial in United States (IFN beta-1a, Dexamethasone)

Terminated
Has Results
  • Covid19
  • Aurora, Colorado
  • +3 more
Oct 13, 2022

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Not yet recruiting
  • Warts
  • Detection of expression of SOCS3 gene
  • +2 more
  • (no location specified)
Mar 12, 2023

Advanced Malignant Solid Tumor, Hepatocellular Carcinoma Trial in Scottsdale (Laboratory Biomarker Analysis, Pharmacological

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • Hepatocellular Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Oct 6, 2021

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Covid19 Trial in Hong Kong (Interferon beta-1b, Remdesivir)

Recruiting
  • Covid19
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Dec 9, 2020

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Interferon-beta (IFN-beta))

Completed
Has Results
  • Multiple Sclerosis
  • Cullman, Alabama
  • +38 more
Oct 8, 2020

COVID Trial in Hong Kong (Interferon Beta-1B, Hydroxychloroquine)

Completed
  • COVID
  • Hong Kong, Hong Kong
    The University of Hong Kong, Queen Mary Hospital
Jul 27, 2020

Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma, Mixed Trial in United States (Interferon-beta)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Interferon-beta
  • Birmingham, Alabama
  • +4 more
Nov 13, 2020

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

Novel Coronavirus Infection Trial in Hong Kong (Lopinavir/ritonavir, Ribavirin, Interferon Beta-1B)

Completed
  • Novel Coronavirus Infection
  • Hong Kong, Hong Kong
    University of Hong Kong, Queen Mary Hospital
Apr 13, 2020

Systemic Lupus Erythematosus (Sle) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Nicotinamide Riboside)

Not yet recruiting
  • Systemic Lupus Erythematosus (Sle)
  • Nicotinamide Riboside
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 15, 2023

Cancer Trial in Philadelphia (recombinant adenovirus-hIFN-beta)

Completed
  • Cancer
  • recombinant adenovirus-hIFN-beta
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 12, 2020

Multiple Sclerosis, Relapsing-Remitting Trial in Italy (dietary supplement, drug, biological)

Terminated
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • D-aspartate
  • +3 more
  • Cagliari, Italy
  • +16 more
Feb 6, 2020

Multiple Sclerosis Trial in Cairo (Blood sample collection)

Recruiting
  • Multiple Sclerosis
  • Blood sample collection
  • Cairo, Egypt
    Nasser Institute for Research and Treatment
Feb 21, 2023

COVID-19, INTERFERON, NEBULIZATION Trial in France (inhaled type I interferon, WFI water nebulization)

Recruiting
  • COVID-19
  • +2 more
  • inhaled type I interferon
  • WFI water nebulization
  • Abbeville, France
  • +6 more
Jan 3, 2022

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 28, 2021

COVID-19 Trial in Kunming (RQ3013, RQ3025, RQ3027)

Recruiting
  • COVID-19
  • RQ3013
  • +2 more
  • Kunming, Yunnan, China
    The Affiliated Hospital of Yunnan University
Jun 22, 2023

Retinal Detachment, Rhegmatogenous Retinal Detachment Trial in Madison (Lamivudine 300 MG, Placebo)

Not yet recruiting
  • Retinal Detachment
  • Rhegmatogenous Retinal Detachment
  • Lamivudine 300 MG
  • Placebo
  • Madison, Wisconsin
    University of Wisconsin
Sep 20, 2023

Mild Cognitive Impairment, Alzheimer Trial in Shiyan, Wuhan (Yeast beta-glucan, Starch)

Active, not recruiting
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Yeast beta-glucan
  • Starch
  • Shiyan, Hubei, China
  • +1 more
Oct 11, 2023

Sarcoma, Kaposi, HIV Trial in Los Angeles, Chicago (Interferon beta-1b, Zidovudine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Los Angeles, California
  • +3 more
Oct 26, 2021

Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Warsaw, Mazowieckie, Poland
  • +1 more
Jun 8, 2023

Innate on the Inflammatory Response to Endotoxin

Recruiting
  • Asthma
  • +4 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Dec 7, 2022

    Healthy Aging Trial in Gainesville (Influenza Vaccine, Beta-glucan, Placebo)

    Recruiting
    • Healthy Aging
    • Influenza Vaccine
    • +2 more
    • Gainesville, Florida
      Food Science and Human Nutrition Department, University of Flori
    Sep 12, 2022

    Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

    Completed
    • Stage III Malignant Melanoma of Skin AJCC V6
    • Stage IV Malignant Melanoma of Skin
    • TAPCells vaccine
    • Santiago, RM, Chile
      Faculty of Medicine, University of Chile
    Nov 21, 2023

    Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

    Not yet recruiting
    • Vaccine Reaction
    • COVID-19
    • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
    • VidPrevtyn® Beta vaccine (Sanofi/GSK)
    • Paris, France
      CIC 1417 Cochin-Pasteur
    Feb 28, 2023